Endeavor System Key Benefits

Harmonising Drug, Polymer and Stent Platform

	Confident deliverability in your hands First cobalt alloy DES Unique modular stent design and thin, edgeless struts enable access to challenging lesions Uniform vessel wall coverage allows excellent drug delivery
	Effective reduction in reintervention rates Consistent treatment effect is achieved in all subgroups ABT-578 is a highly lipophilic sirolimus analogue Discrete Technology protects healthy vessel
	Proven safety with a DES PC Technology polymer has more than seven years of extensive clinical experience Polymer remains biocompatible, leading to minimal inflammation and rapid endothelialisation Broad therapeutic window allows safe control of neointimal hyperplasia